Acrivon Therapeutics, Inc.
ACRVBiotechnology
$1.76−1.68%As of Oct 29vs prior close
- Market cap
- $75.4M
- P/E (TTM)
- –
- From 52W high
- −41.53%
- EPS (LTM)
- -$1.88
- Dividend yield
- 0.00%
Nomior Score
30
Steady ProfileBottom 16% of the scored universe
Growth—
Quality37
Value26
Momentum46
Resilience38